CLASS II ONGOING Device recall · Reported 7 Sep 2022 · FDA Enforcement Report

Vitek 2 / Myla Vitek recalled by bioMerieux

bioMerieux is recalling Vitek 2 / Myla Vitek 2. The recall was initiated on 13 Jul 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVITEK 2 Software Versions 8.01, 8.02 (veterinary only), 9.01, 9.02, 9.03 / MYLA Software Versions V4.8, V4.9 UDI/GTIN: 03573026553968, 03573026619060, 03573026609399, 03573026613914, 03573026619244, 03573026621568

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1640-2022
FDA event ID
90605
Recalling firm
bioMerieux, Durham, NC
Classification
Class II
Status
Ongoing
Recall initiated
13 Jul 2022
FDA classified
26 Aug 2022
Reported
7 Sep 2022
Type
Voluntary: Firm initiated
Reason category
Device Malfunction
Device type
Medical Software

Timeline

13 Jul 2022Recall initiated by company
26 Aug 2022Classified by FDA+44 days
7 Sep 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There are 7 reported software anomalies that may affect use of the device.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

VITEK 2 / MYLA VITEK 2 Software versions 8.01, 8.02 (veterinary use only), 9.01, 9.02, 9.03 MYLA Software versions V4.8 and V4.9

Where it was distributed

International distribution to the countries of Estonia, Bahrain, Pakistan, UK, Singapore, Saudi Arabia, Thailand, and Vietnam.

Questions about this recall

Why was it recalled?

There are 7 reported software anomalies that may affect use of the device.

Which lots are affected?

VITEK 2 Software Versions 8.01, 8.02 (veterinary only), 9.01, 9.02, 9.03 / MYLA Software Versions V4.8, V4.9 UDI/GTIN: 03573026553968, 03573026619060, 03573026609399, 03573026613914, 03573026619244, 03573026621568

Where was it sold?

International distribution to the countries of Estonia, Bahrain, Pakistan, UK, Singapore, Saudi Arabia, Thailand, and Vietnam.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from bioMerieux

All 476

Other Medical Software recalls

All 903